Werbung
Werbung
SNDX
Syndax Pharmaceuticals, Inc.
21.00
USDGesponsert
-0.38
-1.78%
09. Jan., 15:59 UTC -5
Geschlossen
Vor-Markt
21.04
+0.04
+0.17%
SNDX Ergebnisberichte
Positives Überraschungsverhältnis
SNDX übertreffen die 29 der letzten 39Schätzungen.
74%
Nächster Bericht
Datum des nächsten Berichts
02. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$65.38M
/-$0.60
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+42.54%
/-14.29%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+751.34%
/-45.45%
Syndax Pharmaceuticals, Inc. earnings per share and revenue
On 03. Nov. 2025, SNDX reported earnings of -0.70 USD per share (EPS) for Q3 25, beating the estimate of -0.73 USD, resulting in a 4.24% surprise. Revenue reached 45.87 million, compared to an expected 48.94 million, with a -6.26% difference. The market reacted with a +11.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.60 USD, with revenue projected to reach 65.38 million USD, implying an decrease of -14.29% EPS, and increase of 42.54% in Revenue from the last quarter.
FAQ
What were Syndax Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Syndax Pharmaceuticals, Inc. reported EPS of -$0.70, beating estimates by 4.24%, and revenue of $45.87M, -6.26% below expectations.
How did the market react to Syndax Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 11.56%, changed from $13.76 before the earnings release to $15.35 the day after.
When is Syndax Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 02. März 2026.
What are the forecasts for Syndax Pharmaceuticals, Inc.'s next earnings report?
Based on 16
analysts, Syndax Pharmaceuticals, Inc. is expected to report EPS of -$0.60 and revenue of $65.38M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung